These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vagal tone augmentation to the atrioventricular node in humans: efficacy and safety of burst endocardial stimulation. Rossi P; Bianchi S; Monari G; Della Scala A; Porcelli D; Valsecchi S; Canonaco S; Kornet L; Azzolini P Heart Rhythm; 2010 May; 7(5):683-9. PubMed ID: 20206321 [TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733 [TBL] [Abstract][Full Text] [Related]
4. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice. Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314 [TBL] [Abstract][Full Text] [Related]
5. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation. Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026 [TBL] [Abstract][Full Text] [Related]
6. [Atrial defibrillator]. Jung W; Lüderitz B Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804 [TBL] [Abstract][Full Text] [Related]
7. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database. Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M; Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135 [TBL] [Abstract][Full Text] [Related]
8. Management of functional Sprint Fidelis leads at cardiac resynchronization therapy-defibrillator generator replacement: a novel option for preventing inappropriate shocks from lead failure in fragile patients with high risk of sudden death. Zhu DWX; Chu MM; House CM Europace; 2017 Dec; 19(12):2007-2014. PubMed ID: 27940933 [TBL] [Abstract][Full Text] [Related]
9. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF; Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396 [TBL] [Abstract][Full Text] [Related]
10. Endocardial vagal atrioventricular node stimulation in humans: reproducibility on 18-month follow-up. Rossi P; Bianchi S; Valsecchi S; Porcelli D; Sgreccia F; Lucifiero A; Canonaco S; Campoli M; Malavasi M; Piccirillo G; Quaglione R; Azzolini P Europace; 2010 Dec; 12(12):1719-24. PubMed ID: 20876272 [TBL] [Abstract][Full Text] [Related]
11. Atrioventricular (AV) node vagal stimulation by transvenous permanent lead implantation to modulate AV node function: safety and feasibility in humans. Bianchi S; Rossi P; Della Scala A; Kornet L; Pulvirenti R; Monari G; Di Renzi P; Schauerte P; Azzolini P Heart Rhythm; 2009 Sep; 6(9):1282-6. PubMed ID: 19716083 [TBL] [Abstract][Full Text] [Related]
12. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations. Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799 [TBL] [Abstract][Full Text] [Related]
13. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172 [TBL] [Abstract][Full Text] [Related]
14. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators. Ricci RP; Pignalberi C; Landolina M; Santini M; Lunati M; Boriani G; Proclemer A; Facchin D; Catanzariti D; Morani G; Gulizia M; Mangoni L; Grammatico A; Gasparini M; Heart; 2014 Jun; 100(11):848-54. PubMed ID: 24682569 [TBL] [Abstract][Full Text] [Related]
15. Complications of permanent cardiac pacing in patients with persistent left superior vena cava. Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508 [TBL] [Abstract][Full Text] [Related]